CRMD
NASDAQ · Pharmaceuticals
Cormedix Inc
$6.61
+0.15 (+2.32%)
Open$6.58
Previous Close$6.46
Day High$6.71
Day Low$6.52
52W High$17.43
52W Low$5.60
Volume—
Avg Volume1.70M
Market Cap494.07M
P/E Ratio3.03
EPS$1.98
SectorPharmaceuticals
Analyst Ratings
Strong Buy
13 analysts
Price Target
+694.3% upside
Current
$6.61
$6.61
Target
$52.50
$52.50
$41.99
$52.50 avg
$66.46
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 306.83M | 151.82M | 142.81M |
| Net Income | 160.50M | 25.07M | 23.58M |
| Profit Margin | 52.3% | 16.5% | 16.5% |
| EBITDA | 142.05M | 47.08M | 40.68M |
| Free Cash Flow | — | 14.58M | 22.25M |
| Rev Growth | +1,545.2% | +9.9% | -6.7% |
| Debt/Equity | 0.36 | 0.10 | 0.09 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |